Correlation Between Mineralys Therapeutics, and AC Immune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and AC Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and AC Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and AC Immune, you can compare the effects of market volatilities on Mineralys Therapeutics, and AC Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of AC Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and AC Immune.

Diversification Opportunities for Mineralys Therapeutics, and AC Immune

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Mineralys and ACIU is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and AC Immune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AC Immune and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with AC Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AC Immune has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and AC Immune go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and AC Immune

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the AC Immune. In addition to that, Mineralys Therapeutics, is 1.07 times more volatile than AC Immune. It trades about -0.05 of its total potential returns per unit of risk. AC Immune is currently generating about 0.14 per unit of volatility. If you would invest  300.00  in AC Immune on August 28, 2024 and sell it today you would earn a total of  41.00  from holding AC Immune or generate 13.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  AC Immune

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in December 2024.
AC Immune 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in AC Immune are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating forward indicators, AC Immune may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Mineralys Therapeutics, and AC Immune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and AC Immune

The main advantage of trading using opposite Mineralys Therapeutics, and AC Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, AC Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will offset losses from the drop in AC Immune's long position.
The idea behind Mineralys Therapeutics, Common and AC Immune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories